Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Topline data were announced from a phase 3 trial evaluating CagriSema (cagrilintide/semaglutide) in overweight or obese patients with type 2 diabetes.

For her first performance, Lizzo wowed in a black leather plunging bodysuit paired with silver hot pants which highlighted her slimmed-down figure. The About Damn Time hitmaker finished her look with ...

When best friends AnnaLee Canario and Dacia Benjamin started taking weight loss drugs together they thought it would be an ...

Early-life gut microbes could play a key role in protecting against diabetes. A healthy start for a healthier future.

Stanford Medicine researchers have identified a naturally occurring molecule that mimics the appetite-suppressing effects of ...

Despite the current downward trend of NVO, it is a good stock to retain in one's portfolio for long-term gains due to strong ...

Dosing underway in INLIGHT trial of WVE-007 in obesity with clinical data expected in 2H 2025; enrollment complete in first single dose cohort Multi-dosing ongoing in 200 mg cohort of RestorAATion-2 ...

The FDA has declared that the shortage of popular weight-loss drugs, including Ozempic and Wegovy, is officially over.

Although the telemedicine company displayed blistering growth and issued robust guidance, shares of Hims & Hers (NYSE: HIMS) ...

Scientists in China have found a new potential drug target for weight loss. Blocking a protein called CD44 has been shown to ...

Higher weight loss after initiating antiobesity meds linked to lower risk for revision of hip and knee replacement. HealthDay News — For patients with obesity undergoing joint replacement ...